AN2 Therapeutics, Inc.ANTXNASDAQ
Loading
Selling, general, and administrative expenses
3Y CAGR
+1.5%/yr
Annual compound
5Y CAGR
+60.2%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
10.5x
Strong expansion
Streak
2 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $13.34M | -5.2% |
| 2024 | $14.07M | -4.7% |
| 2023 | $14.76M | +15.8% |
| 2022 | $12.75M | +173.2% |
| 2021 | $4.67M | +269.0% |
| 2020 | $1.26M | -27.0% |
| 2019 | $1.73M | - |